Up-regulated cytoplasmic expression, with reduced membranous distribution, of thesrc substrate p120ctn in gastric carcinoma
- 1 October 1999
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 189 (2) , 180-185
- https://doi.org/10.1002/(sici)1096-9896(199910)189:2<180::aid-path414>3.0.co;2-2
Abstract
P120ctn is a substrate of the tyrosine kinase pp60 src. Tyrosine kinases such as src localize to the adherens junctions and phosphorylate junctional proteins in both normal and transformed cells.1 p120ctn forms a complex with E-cadherin at the adherens junction and is phosphorylated by ligands such as epidermal growth factor receptor as well as pp60 src. Phosphorylation of p120ctn has been shown to correlate with cell transformation. The aim of this study was to investigate in vivo expression of p120ctn in gastric carcinoma and to examine any relationship to pathological characteristics and patient survival. Immunohistochemical staining for p120ctn was performed in 68 gastric carcinoma specimens (19 diffuse, 49 intestinal type), in 22 lymph node metastases, and in gastric mucosal biopsies from 16 patients with gastric dysplasia and ten healthy controls. Up-regulation of p120ctn cytoplasmic staining was seen in six (37 per cent) of the gastric dysplasia cases and in 45 (66 per cent) tumours (89 per cent of diffuse and 57 per cent of intestinal tumours). Loss of membranous distribution of staining for p120ctn was seen in 22 (32 per cent) tumours (52 per cent of diffuse and 24 per cent of intestinal tumours). The staining pattern in the primary tumour showed no correlation with tumour type, grade, or stage, or patient survival. Of 22 lymph node metastases examined, 13 (60 per cent) showed loss of membranous staining. In conclusion, staining for p120ctn in gastric carcinoma and dysplasia revealed marked up-regulation of cytoplasmic staining, sometimes associated with reduced membranous expression. Up-regulation of expression of p120ctn has not previously been described in human epithelial malignancy. The significance of these findings is uncertain, but they may reflect a change in tyrosine kinase signal transduction pathways, and a role for p120ctn in ligand-induced mitogenic signalling and cell transformation. Copyright © 1999 John Wiley & Sons, Ltd.Keywords
This publication has 31 references indexed in Scilit:
- Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon CarcinomaScience, 1997
- Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: Relationship with patient survivalGastroenterology, 1997
- Functional interaction of β-catenin with the transcription factor LEF-1Nature, 1996
- Density-Dependent Inhibition of Growth Involves Prevention of EGF Receptor Activation by E-Cadherin-Mediated Cell–Cell AdhesionExperimental Cell Research, 1996
- The Novel Catenin p120casBinds Classical Cadherins and Induces an Unusual Morphological Phenotype in NIH3T3 FibroblastsExperimental Cell Research, 1996
- The Gene Encoding p120cas, a Novel Catenin, Localizes on Human Chromosome 11q11 (CTNND) and Mouse Chromosome 2 (Catns)Genomics, 1996
- Association of p120, a tyrosine kinase substrate, with E-cadherin/catenin complexes.The Journal of cell biology, 1995
- Specific proto-oncogenic tyrosine kinases of src family are enriched in cell-to-cell adherens junctions where the level of tyrosine phosphorylation is elevated.The Journal of cell biology, 1991
- Cadherin Cell Adhesion Receptors as a Morphogenetic RegulatorScience, 1991
- Association between the PDGF receptor and members of the src family of tyrosine kinasesCell, 1990